Prophylactic norepinephrine combined with 6% hydroxyethyl starch (130/0.4) co-load infusion for preventing postspinal...

Area of Science:

• Anesthesiology
• Obstetrics
• Pharmacology

Background:

• Postspinal anesthesia hypotension is a common complication during cesarean sections.
• Colloid co-load infusions may offer superior prevention compared to crystalloids.
• Optimizing prophylactic vasopressor use is crucial for maternal and fetal well-being.

Purpose of the Study:

• To evaluate the efficacy of varying prophylactic norepinephrine dosages combined with colloid co-load for preventing postspinal anesthesia hypotension.
• To determine the optimal norepinephrine dosage for maintaining hemodynamic stability during cesarean section under spinal anesthesia.

Main Methods:

• A randomized trial involving 175 patients undergoing cesarean section and spinal anesthesia.
• Patients received 500 mL 6% hydroxyethyl starch co-load followed by one of five prophylactic norepinephrine dosages (0 to 0.1 µg/kg/min).
• The primary outcome was the incidence of hypotension, defined as systolic blood pressure <80% of baseline.

Main Results:

• Hypotension incidence decreased significantly with increasing norepinephrine dosage, from 48.6% to 5.7% (p < 0.001).
• Norepinephrine effectively stabilized systolic blood pressure relative to baseline.
• The effective dose (ED50) and ED90 for preventing hypotension were determined to be -0.006 and 0.081 µg/kg/min, respectively.

Conclusions:

• A prophylactic norepinephrine dosage of 0.05 µg/kg/min, combined with a colloid co-load, is optimal for preventing postspinal anesthesia hypotension during cesarean section.
• This regimen effectively mitigates hypotension and maintains hemodynamic stability.
• The findings provide evidence-based guidance for anesthetic management in cesarean deliveries.